Impact Health NDAC Meeting

1. Impact Health NDAC Meeting Stewart Levy R.Ph. January 14, 2005

2. Agenda • Introduction to Impact Health and the Biometric Testing Industry • Scope of services and examples of consumer outreach projects • Process for cholesterol screening programs • Results from programs and need for Cholesterol screenings / overall CV Health Education • Retail Venue Challenges and Opportunities • Impact of OTC Statins on the Biometric Testing Industry

3. The Mission of Impact Health As the country’s leading Clinical Marketing and Biometric Testing Organization, our mission is to provide a clinical experience to consumers creating a “teachable moment” that promotes healthy decisions related to products, services and lifestyle.

4. Impact Health Sample List of Customers • Advocacy Groups • Agencies • Consumer Organizations • Employers • Health Promotion Companies • Food Companies • Managed Care Organizations • OTC Companies • Pharmaceutical Industry • Pharmacy Chains

5. Impact Health Background Information • 17 years of existence • Hold Federal CLIA certification and approval in individual states where required • Act in accordance to HIPPA guidelines • Carries professional liability insurance that covers clinical testing • Maintains an active quality assurance program which includes a comprehensive set of policies, procedures, and practices necessary to assure that the laboratory's results are reliable • Participates in mandatory and optional proficiency testing programs • Training includes clinical relevance, testing protocols, counseling, OSHA blood borne pathogens, HIPAA guidelines and more

6. Types of organizations that perform community cholesterol screenings • Local Biometric Screening Companies – “Cottage industry” • Few National Firms • Local Hospitals • Advocacy Groups with volunteers • Temporary Nursing Staffing Firms

7. Biometric Screening - Scope of Services • Consulting and Marketing Development • Health Risk Assessment – Utilization of validated assessment tool to identify and stratify risk • Clinical Testing – Utilization of CLIA waived technology • Health Education – Counseling based on ATP III and JNC VII norms • Screening not Diagnostic – Those “at risk” are encouraged to speak with their healthcare provider • Data and Reporting • Aggregate Reports • Follow-up communication to participant and physician • Market Research • Outcomes measurements

8. Cardiovascular Consumer Education Process Data Collection Paper or ComputerRegistration Risk Evaluation - “Teachable Moment” Counseling and Distribution of brochures on cholesterol management Send results to physician Cholesterol Testing

9. Rationale for Cholesterol Testing 2002 Rx Company Sponsored Initiative • 52% of the respondents did not know their cholesterol level before the screening event • 34% of respondents contacted their doctor about managing their cholesterol after the event • 57% of the people who contacted their doctor did so within one month • 36% of the people who contacted their doctor reported that they were prescribed medication to manage their cholesterol • 28% paid more attention to prescription drug advertisements after the screening event • 60% of those surveyed would return at least once or twice a year for screening; 37% even more often • 80% of the people surveyed agreed that screenings are a good place to learn about health and health care products to manage cholesterol • 52% preferred screening events to television, magazine or other DTC marketing as an information source * Refer to Taking Action: Screening Programs Motivate Consumer Behavior Research for details

10. Examples of Cholesterol Screening Programs • Multicultural Cholesterol Awareness – Sana La Rana community outreach campaign to educate latino consumers about CV risks • Advocacy Group Programs – Sister to Sister Program - provide cholesterol screening and education to women • Retail Screening Campaigns – • WalMart Cholesterol Program – 140,000 consumers during February 04 • 2005 Walgreens Wellness Tour – 24 states • Pharmaceutical Company – “Tune up for Health” • Employer Programs – Various ongoing programs to reduce health care costs

11. Walgreens Wellness Tour

12. Retail Venue Challenges • Pharmacist Training for Clinical Testing • Staffing issues – Outsourcing • Marketing screening at local level • Regulatory and Quality Control Standards • Space Requirements • Logistics Management

13. Retail Venue Opportunities • Convenience of retail site as a venue for Cholesterol health education • Pharmacist professional knowledge • Retail marketing resources instore radio, flyers, circulars, databases to invite people into health fair • Consumers ongoing presence at a retail location • OTC, food and Rx therapeutic options for treatment available at retail

14. Impact of OTC Statins on the Biometric Testing Industry The biometric industry may need to respond to the launch of OTC statins with the following strategies: • Develop professional staff to support retailers who may be interested in outsourcing their screening services • Develop to develop field-based consultative services for those retailers who are interested in screening themselves in partnership with organizations that will train pharmacists • Link education about OTC statins to screening programs performed in other venues e.g. Employers • Develop health educational resources, with OTC statin companies, to distribute during counseling to insure appropriate consumers consider OTC statin utilization.